Metabolic Dysfunction-associated Steatohepatitis
📧 Sign up to get email alerts when something new happens for Metabolic Dysfunction-associated Steatohepatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Safety, Tolerability, PK, PD, and Immunogenicity of QL2401 in Healthy Chinese Adults [Phase 1]
Phase 1 study evaluating safety, tolerability, pharmacokinetics, pharmacodynamics, and immunogenicity of QL2401 in healthy Chinese adults fo…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Study of PNPLA3 Genetic Polymorphisms in Patients With Non-Alcoholic Fatty Liver Disease in an Ultramarine Population (AdipoDROMExpo)
A clinical-trial update describes a study of PNPLA3 genetic variants in patients with MASLD/MASH in Guadeloupe. The study is currently recru…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Betaine vs. Placebo for Serologically Diagnosed Metabolic Dysfunction-associated Steatohepatitis (MASH) [Phase 2]
Phase 2 clinical trial comparing betaine to placebo for serologically diagnosed metabolic dysfunction-associated steatohepatitis (MASH); the…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Thermoacoustic Method for Estimating Liver Fat Fraction
Clinical trial investigating a thermoacoustic method to estimate liver fat fraction in MASLD/MASH and nonalcoholic fatty liver disease, curr…
-
CLINICAL_TRIALS research · 2026-01-05Clinical Trial Update: A Study of Chiglitazar in Patients With Metabolic Dysfunction-associated Steatohepatitis and Type 2 Diabetes Mellitus [Phase 2]
Phase 2 clinical trial investigating Chiglitazar in patients with metabolic dysfunction-associated steatohepatitis and type 2 diabetes melli…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH [Phase 2]
A Phase 2 study evaluating Efimosfermin Alfa in participants with biopsy-confirmed compensated cirrhosis due to Metabolic Dysfunction-Associ…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Resmiterom Efficacy & Safety in Patients With MASH [Phase 4]
A Phase 4 clinical trial update indicating that Resmiterom is being studied for efficacy and safety in metabolic dysfunction-associated stea…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: A Study of UBT251 in Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH) [Phase 2]
UBT251 is being studied in Phase 2 for metabolic dysfunction-associated steatohepatitis (MASH). The study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: A Study of IBI362 in Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH) [Phase 2]
This is a Phase 2 clinical trial evaluating IBI362 for metabolic dysfunction-associated steatohepatitis (MASH), currently recruiting.
-
CLINICAL_TRIALS research · 2025-10-31Clinical Trial Update: Digoxin In NASH (CODIN) [Phase 2]
Phase 2 trial (CODIN) evaluating digoxin for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: Patients' Perspectives on Metabolic Dysfunction-associated Steatohepatitis: a Qualitative Study
This clinical trial update describes a qualitative study to explore patients' perspectives on metabolic dysfunction-associated steatohepatit…
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Endoscopic Ultrasound Shear Wave Elastography Study
Clinical trial update on endoscopic ultrasound shear wave elastography to assess liver stiffness in patients with metabolic dysfunction-asso…
-
CLINICAL_TRIALS research · 2025-08-22Clinical Trial Update: Fibrosis Lessens After Metabolic Surgery [Phase 4]
Phase 4 clinical trial update exploring metabolic surgery to reduce liver fibrosis in metabolic dysfunction-associated steatotic liver disea…
-
CLINICAL_TRIALS research · 2025-08-15Clinical Trial Update: Evaluation of a New Ultrasound System for the Non-invasive Assessment of Liver Steatosis in MASLD/MASH Patients [NA]
Ongoing clinical trial evaluating a new ultrasound system for non-invasive assessment of liver steatosis in MASLD/MASH patients.
-
CLINICAL_TRIALS research · 2025-07-23Clinical Trial Update: Fructose is a Metabolic and Inflammatory Pathogenic Factor in Metabolic Dysfunction-associated Steatohepatitis (MASH) [NA]
A clinical trial at Queen Mary University of London is examining fructose as a metabolic and inflammatory factor in metabolic dysfunction-as…
-
CLINICAL_TRIALS research · 2025-06-18Clinical Trial Update: Effect of Sinbiotic With Multispecies Probiotics on Liver Parameters Liver Enzymes, Ultrasound, Elastography and Adipokines in Same Cases) in Patients With Metabolic Associated Steatotic Liver Disease. [Phase 2]
Phase 2 clinical trial evaluating the effect of a sinbiotic with multispecies probiotics on liver parameters in patients with MASLD/MASH; tr…
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: To Evaluate the Tolerability, Pharmacokinetics, and Pharmacodynamics of IMM-H014 in Patients With MASH [Phase 1, Phase 2]
A Phase 1/2 clinical trial update for IMM-H014 to assess tolerability, pharmacokinetics, and pharmacodynamics in patients with Metabolic Dys…
-
CLINICAL_TRIALS research · 2025-04-02Clinical Trial Update: Long-term Follow-up to Determine Outcome in Liver Disease (LOVE Study)
This clinical trial update describes the LOVE study's long-term follow-up to determine outcomes in MASLD/MASH and related steatotic liver di…
-
CLINICAL_TRIALS research · 2025-02-12Clinical Trial Update: Clinical Classification of MAFLD Based Liver Biopsy
This clinical trial registry entry describes a study on classifying MAFLD using liver biopsy and notes that it is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-01-08Clinical Trial Update: Characterization and Management of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) [NA]
A clinical trial update focusing on characterizing and managing metabolic dysfunction-associated fatty liver disease (MAFLD) and its associa…
-
CLINICAL_TRIALS research · 2024-11-01Clinical Trial Update: New Non-invasive Biomarkers of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)
This document provides an update on the development of new non-invasive biomarkers for metabolic dysfunction-associated steatotic liver dise…
-
CLINICAL_TRIALS research · 2024-08-29Clinical Trial Update: A Microdose Trial Investigating Binding of [68Ga]Ga-DOTA-CYS-ATH001 in Healthy Subjects and Different Patient Groups. [EARLY_Phase 1]
Early-phase microdose clinical trial evaluating binding of the radiotracer [68Ga]Ga-DOTA-CYS-ATH001 in healthy volunteers and patients with …
-
CLINICAL_TRIALS research · 2024-08-01Clinical Trial Update: Global Research Initiative for Patients Screening on MASH
A clinical trial update shows recruitment is ongoing for the Global Research Initiative for Patients Screening on MASH, enrolling participan…
-
CLINICAL_TRIALS research · 2024-06-06Clinical Trial Update: Acceptability and Feasibility of a New Approach to Engage Patients With Steatotic Liver Disease in Physical Activity [NA]
A clinical trial update describing a new approach to engage patients with steatotic liver disease in physical activity; the study is not yet…